Skip to main content

Medication & Treatment

People with diabetes use many medications to both manage blood sugar levels and also to prevent or treat health complications.

For people with type 1 diabetes, the most important drug is insulin; some people with type 2 diabetes also take insulin. For people with type 2 diabetes, glucose-lowering medications include metformin, sulfonylureas, TZDs, SGLT-2 inhibitors, GLP-1 agonists, DPP-4 inhibitors, and more.

Some of these drugs are injected, others are taken in pill form, and some are even inhaled. Learn about the different treatment options available and which might be best for your lifestyle.

SGLT-2 inhibitors
GLP-1 agonists
DPP-4 inhibitors
Combination drugs
Sulfonylureas (SFUs)

What's new

diabetic eye disease treatment Vabysmo

Vabysmo, a new drug manufactured by Roche, was recently approved by the FDA to treat two common eye diseases. Find out more about this medication and how it might help you. Continue Reading »

Learn more about this clinical trial by Novo Nordisk, that is testing whether a new medication, when combined with semaglutide (also known as Wegovy), can help people with type 2 diabetes lower their glucose levels and lose weight.  Continue Reading »

If you are a new or existing user of Medtronic's MiniMed pumps, read more about what immediate steps you need to take to avoid serious injuries. Continue Reading »

Are you currently taking metformin but not meeting your A1C goals? Join a study looking to compare Rybelsus (oral semaglutide) with other oral diabetes drugs to see how it can improve your glucose levels. Continue Reading »

​Exercising with diabetes is important, but it does provide some additional challenges. Learn how to navigate being an athlete while managing your diabetes from experts. Continue Reading »

As scientific researchers continue to make strides toward a cure for type 1 diabetes, diaTribe sat down with Sean Kramer, the CEO of the Diabetes Research Institute Foundation and a person with type 1 himself, to discuss the latest in the search for a cure. Continue Reading »

The American Diabetes Association released its 2022 Standards of Care, which provides an annual update on practice guidelines. Here's what these new updates mean, including your options for first-line glucose-lowering therapies, when you should be screened for diabetes, the expanded use of diabetes care technology, and more. Continue Reading »

Lilly’s new basal insulin, Rezvoglar, may provide a cheaper alternative to Lantus. This marks the second approval of a biosimilar long-acting insulin. Continue Reading »